Answers are grounded in this paper and cite their sources.
Case reports present varied clinical phenotypes in children with MDA5 autoantibodies, suggesting tailored management is vital.
These cases highlight the wide heterogeneity of clinical phenotypes associated with anti-MDA5 autoantibodies in JDM. Given this variability, individualized monitoring and management strategies are essential to optimize outcomes.
No takes yet. Share an insight, caveat, or question.
Lepage et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: